Literature DB >> 22959867

Effects of age and chronic kidney disease on regional aortic distensibility: a cardiovascular magnetic resonance study.

Colin D Chue1, Nicola C Edwards, Charles J Ferro, Jonathan N Townend, Richard P Steeds.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is associated with increased arterial stiffness, an independent predictor of adverse cardiovascular outcome. Effects of CKD on regional aortic stiffness are unknown. This study aimed to determine the effects of CKD and ageing on regional thoracic aortic distensibility using cardiac magnetic resonance (CMR) imaging.
METHODS: This was a cross-sectional case control study comparing patients with stage II-IV non-diabetic CKD recruited from a university hospital with healthy controls. Aortic distensibility was measured in triplicate using CMR (1.5 T) at ascending, proximal descending and distal descending thoracic aortic levels and calculated using previously validated formulae.
RESULTS: 189 patients and 40 controls were recruited. Distensibility was reduced at all three thoracic aortic levels in CKD patients compared to controls (2.8 vs. 4.1 × 10(-3) mmHg(-1); P < 0.0005 for ascending aorta). The cohort was divided into tertiles of age and glomerular filtration rate (GFR); distensibility decreased with increasing age (P < 0.0005) and decreasing GFR (P < 0.02). In univariate analyses age (r = -0.688, P < 0.0005), systolic blood pressure (r = -0.183, P = 0.006) and GFR (r = 0.172, P = 0.009) all correlated with ascending aortic distensibility. In a multivariate regression model age and GFR were independent predictors of aortic distensibility at all three levels with 50% of the variation in ascending aortic distensibility explained (P < 0.0005).
CONCLUSIONS: Patients with early stage chronic kidney disease have reduced distensibility along the entire length of the thoracic aorta. This worsens with ageing and as kidney function declines, emphasizing the importance of early treatment whilst kidney function is still relatively preserved.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aortic distensibility; Aortic stiffness; Cardiac magnetic resonance imaging; Chronic kidney disease

Mesh:

Year:  2012        PMID: 22959867     DOI: 10.1016/j.ijcard.2012.08.007

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Chronic kidney disease and cardiovascular complications.

Authors:  Luca Di Lullo; Andrew House; Antonio Gorini; Alberto Santoboni; Domenico Russo; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

2.  Age-dependent ascending aorta mechanics assessed through multiphase CT.

Authors:  Caitlin Martin; Wei Sun; Charles Primiano; Raymond McKay; John Elefteriades
Journal:  Ann Biomed Eng       Date:  2013-07-02       Impact factor: 3.934

3.  Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors.

Authors:  William E Moody; Charles J Ferro; Nicola C Edwards; Colin D Chue; Erica Lai Sze Lin; Robin J Taylor; Paul Cockwell; Richard P Steeds; Jonathan N Townend
Journal:  Hypertension       Date:  2016-02       Impact factor: 10.190

4.  Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial.

Authors:  M P M Graham-Brown; D S March; D R Churchward; H M L Young; M Dungey; S Lloyd; N J Brunskill; A C Smith; G P McCann; J O Burton
Journal:  BMC Nephrol       Date:  2016-07-08       Impact factor: 2.388

5.  Investigating the effects of 6 months extended duration, in-centre nocturnal versus conventional haemodialysis treatment: a non-randomised, controlled feasibility study.

Authors:  Darren R Churchward; Matthew P M Graham-Brown; Robert Preston; Warren Pickering; Gerry P McCann; James O Burton
Journal:  BMJ Open       Date:  2016-09-08       Impact factor: 2.692

6.  Impaired aortic strain and distensibility by cardiac MRI in children with chronic kidney disease.

Authors:  Donia M Sobh; Ahmed M Tawfik; Nihal M Batouty; Hoda M Sobh; Nashwa Hamdy; Ashraf Bakr; Riham Eid; Mohamed H Awad; Basma Gadelhak
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

Review 7.  Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.

Authors:  Wen-Juan Wang; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Oncotarget       Date:  2017-04-21

8.  A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.

Authors:  Manvir K Hayer; Nicola C Edwards; Gemma Slinn; William E Moody; Rick P Steeds; Charles J Ferro; Anna M Price; Cecilio Andujar; Mary Dutton; Rachel Webster; David J Webb; Scott Semple; Iain MacIntyre; Vanessa Melville; Ian B Wilkinson; Thomas F Hiemstra; David C Wheeler; Anna Herrey; Margaret Grant; Samir Mehta; Natalie Ives; Jonathan N Townend
Journal:  Am Heart J       Date:  2017-05-24       Impact factor: 4.749

9.  The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease.

Authors:  Sherna F Adenwalla; Matthew P M Graham-Brown; Francesca M T Leone; James O Burton; Gerry P McCann
Journal:  Clin Kidney J       Date:  2017-05-10

10.  Association between central aortic pulsatility and glomerular filtration rate in patients with coronary artery disease.

Authors:  Serkan Duyuler; Pınar Türker Bayır; Ümit Güray; Abdülkadir Yıldız; Ahmet Korkmaz; Kadir Gökhan Atılgan
Journal:  Anatol J Cardiol       Date:  2015-11-30       Impact factor: 1.596

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.